NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM7698006 Query DataSets for GSM7698006
Status Public on Aug 14, 2023
Title HL60_COMBO_2
Sample type SRA
 
Source name hematopoetic
Organism Homo sapiens
Characteristics tissue: hematopoetic
cell line: HL-60
cell type: non-adherent
treatment: Decitabine+Simvastatin
Treatment protocol HL-60 cells in each group (DMSO, DAC 0.5 μM, simvastatin 10 μM, and DAC+simvastatin) were harvested 36 hours after exposure to each treatment
Growth protocol HL-60 (CCL-240, ATCC) cells were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) and 1% P/S.
Extracted molecule total RNA
Extraction protocol Total RNA was extracted using an RNeasy Mini Kit (Qiagen), and RNA integrity and purity were checked using Agilent 2100 Bioanalyzer (Agilent Technologies). 1.0μg of total RNA was used for the construction of sequencing libraries.
After mRNA enrichment using oligo(dT) beads and rRNA depletion using the Ribo-Zero Plus rRNA Depletion Kit (Illumina), cDNA was synthesized using an mRNA template and random primers, second-strand synthesis buffer, dNTPs, RNase H and DNA polymerase I. The double-stranded cDNA library was completed by “A” base ligation and sequencing adaptor ligation. The quality and quantity of these libraries were checked using Qubit 2.0 (Thermo Fisher Scientific), Agilent 2100, and quantitative PCR using the Real-time PCR Systems Step One Plus (Applied Biosystems).
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina NovaSeq 6000
 
Data processing Read quality was confirmed using FastQC.
Sequence reads were trimmed for adaptor sequence/low-quality sequence.
These reads were aligned to the GRCh38 reference genome using the HISAT2 pipeline.
Transcripts per million (TPM) were calculated based on the length of the gene and the number of reads mapped to each gene.
Differential expression analysis among each group was performed using the DESeq2 R package.
Assembly: GRCh38
Supplementary files format and content: tab-delimited text file includes raw counts for each sample.
Supplementary files format and content: tab-delimited text file includes TPM counts for each sample.
 
Submission date Aug 09, 2023
Last update date Aug 14, 2023
Contact name Tomohiro Yabushita
E-mail(s) [email protected]
Organization name The University of Tokyo
Street address 7-3-1, Hongou, Bunkyo-ku
City Tokyo
ZIP/Postal code 113-8654
Country Japan
 
Platform ID GPL24676
Series (1)
GSE240439 Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment
Relations
BioSample SAMN36905477
SRA SRX21310551

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap